Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

(S)-Oxiracetam is the Active Ingredient in Oxiracetam that Alleviates the Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats.

Li W, Liu H, Jiang H, Wang C, Guo Y, Sun Y, Zhao X, Xiong X, Zhang X, Zhang K, Nie Z, Pu X.

Sci Rep. 2017 Aug 30;7(1):10052. doi: 10.1038/s41598-017-10283-4.

2.

Enantioselective HPLC determination of oxiracetam enantiomers and application to a pharmacokinetic study in beagle dogs.

Zhang Q, Yang W, Zhang Q, Yang Y, Li J, Lu Y, Zheng Y, He J, Zhao D, Chen X.

J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Jul 1;993-994:9-13. doi: 10.1016/j.jchromb.2015.04.033. Epub 2015 Apr 30.

PMID:
25978861
3.

Glycosides of cistanche improve learning and memory in the rat model of vascular dementia.

Chen J, Zhou SN, Zhang YM, Feng YL, Wang S.

Eur Rev Med Pharmacol Sci. 2015 Apr;19(7):1234-40.

4.

Comparative pharmacokinetic studies of racemic oxiracetam and its pure enantiomers after oral administration in rats by a stereoselective HPLC method.

Zhang Q, Yang W, Yang Y, Xing H, Zhang Q, Li J, Lu Y, He J, Yang S, Zhao D, Chen X.

J Pharm Biomed Anal. 2015;111:153-8. doi: 10.1016/j.jpba.2015.03.039. Epub 2015 Apr 4.

PMID:
25886392
5.

Catalpol Induces Neuroprotection and Prevents Memory Dysfunction through the Cholinergic System and BDNF.

Wan D, Xue L, Zhu H, Luo Y.

Evid Based Complement Alternat Med. 2013;2013:134852. doi: 10.1155/2013/134852. Epub 2013 Sep 8.

6.

[Protective effect of oxiracetam on traumatic brain injury in rats].

Li JW, Yang DJ, Chen XY, Liang HQ.

Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2013 Jul;29(4):298-300. Chinese.

PMID:
24175546
7.

Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.

Malykh AG, Sadaie MR.

Drugs. 2010 Feb 12;70(3):287-312. doi: 10.2165/11319230-000000000-00000. Review.

PMID:
20166767
8.

Oxiracetam pre- but not post-treatment prevented social recognition deficits produced with trimethyltin in rats.

Hlinák Z, Krejcí I.

Behav Brain Res. 2005 Jun 20;161(2):213-9. Epub 2005 Mar 31.

PMID:
15922047
9.

Oxiracetam prevented the scopolamine but not the diazepam induced memory deficits in mice.

Hlinák Z, Krejcí I.

Behav Brain Res. 2002 Jul 18;133(2):395-9.

PMID:
12110475
10.
11.

Oxiracetam prevents the MK-801 induced amnesia for the elevated plus-maze in mice.

Hlinák Z, Krejcí I.

Behav Brain Res. 2000 Dec 20;117(1-2):147-51.

PMID:
11099768
12.

Effects of ACE-inhibitors on learning and memory processes in rats.

Nikolova JG, Getova DP, Nikolov FP.

Folia Med (Plovdiv). 2000;42(1):47-51.

PMID:
10979177
13.

Influence of piracetam and oxiracetam on the content of high-energy phosphates and morphometry of astrocytes in vitro.

Gabryel B, Trzeciak HI, Pudełko A, Cieślik P.

Pol J Pharmacol. 1999 Nov-Dec;51(6):485-95.

PMID:
10817526
15.

Effect of alaptide, its analogues and oxiracetam on memory for an elevated plus-maze in mice.

Hlinák Z, Vinsová J, Kasafírek E.

Eur J Pharmacol. 1996 Oct 24;314(1-2):1-7.

PMID:
8957212
16.

The GABAB receptor antagonist CGP 36,742 and the nootropic oxiracetam facilitate the formation of long-term memory.

Mondadori C, Möbius HJ, Borkowski J.

Behav Brain Res. 1996 May;77(1-2):223-5.

PMID:
8762175
17.

Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions.

Bartolini L, Casamenti F, Pepeu G.

Pharmacol Biochem Behav. 1996 Feb;53(2):277-83.

PMID:
8808132
18.
19.

Kynurenic acid and 5,7-dichlorokynurenic acids improve social and object recognition in male rats.

Hlinák Z, Krejci I.

Psychopharmacology (Berl). 1995 Aug;120(4):463-9.

PMID:
8539328
20.

Clinical pharmacokinetics of drugs for Alzheimer's disease.

Parnetti L.

Clin Pharmacokinet. 1995 Aug;29(2):110-29. Review.

PMID:
7586900

Supplemental Content

Loading ...
Support Center